Association of visceral adiposity index with sarcopenia based on NHANES data
Jianzhao Li,
No information about this author
Yuning Lin,
No information about this author
Haitang Deng
No information about this author
et al.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Sept. 10, 2024
The
Visceral
Adiposity
Index
(VAI)
assesses
visceral
fat
and
related
metabolic
risks.
However,
its
precise
correlation
with
sarcopenia
is
unclear.
This
study
aimed
to
examine
this
correlation.
A
cross-sectional
analysis
was
conducted
using
NHANES
data
from
2011
2018.
To
correct
VAI
skewness,
a
logarithmic
transformation
applied.
Multiple
covariates
were
included,
logistic
regression
employed
explore
the
relationship
between
sarcopenia.
Restricted
cubic
spline
(RCS)
threshold
saturation
analyses
used
investigate
nonlinear
relationship.
Subgroup
evaluated
effects
of
various
stratification
factors.
Sensitivity
additive
tested
robustness
findings.
included
4688
individuals.
Participants
had
significantly
higher
values.
Logistic
revealed
significant
positive
connection
Log
(OR
2.09,
95%
CI
1.80-2.43)
after
adjusting
for
variables.
RCS
showed
correlation,
identifying
breakpoint
at
=
1.51.
left
breakpoint,
each
unit
increase
in
correlated
likelihood
2.54,
1.74-3.79);
right,
increases
did
not
affect
prevalence.
suggested
as
an
independent
risk
factor.
confirmed
main
findings'
robustness.
Among
American
adults,
associated
sarcopenia,
values
potentially
increasing
prevalence
Monitoring
critical
early
identification
high-risk
individuals
interventions
delay
or
minimize
onset
progression
Language: Английский
Prevalence and Predictive Features of CT‐Derived Nonalcoholic Fatty Liver Disease in Metabolically Healthy MACS
Burcu Candemir,
No information about this author
Kadir Kisip,
No information about this author
Şafak Akın
No information about this author
et al.
Clinical Endocrinology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 2, 2025
ABSTRACT
Objective
Patients
with
mild
autonomous
cortisol
secretion
(MACS)
are
at
increased
risk
of
cardiometabolic
outcomes,
such
as
hyperglycemia,
metabolic
syndrome,
and
cardiovascular
diseases.
Nonalcoholic
fatty
liver
disease
(NAFLD)
is
also
associated
risk.
We
aimed
to
investigate
the
prevalence
predictors
NAFLD
in
metabolically
healthy
subjects
MACS.
Methods
Forty
patients
MACS
60
nonfunctioning
adrenal
incidentaloma
(NFAI)
matched
for
age,
gender,
body
mass
index
were
included.
excluded
various
diseases
that
may
lead
NAFLD,
diabetes,
diseases,
disorders.
Non‐alcoholic
was
evaluated
unenhanced
abdominal
computed
tomography
noninvasive
indices.
Results
had
lower
mean
attenuation
values
(Hounsfield
units,
HU)
than
those
NFAI
(
p
=
0.001).
Visceral
adiposity
index,
hepatic
steatosis
higher
group
0.009,
0.002,
0.023,
respectively).
However,
there
no
significant
association
between
HU
value
these
There
a
serum
level
after
1
mg
dexamethasone
suppression
test
(DST)
independent
other
traditional
factors
models
performed
multivariable
linear
regression
analysis.
Conclusions
Our
findings
suggest
an
DST
predictor
Language: Английский
Personalized approach in the management of women with heart failure with preserved ejection fraction and carbohydrate metabolism disorders
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine),
Journal Year:
2025,
Volume and Issue:
20(8), P. 622 - 632
Published: Jan. 4, 2025
Background.
The
progression
of
heart
failure
(HF)
in
individuals
with
carbohydrate
metabolism
disorders
is
one
the
many
fatal
complications
among
comorbid
conditions.
It
found
that
risk
developing
HF
women
diabetes
mellitus
(DM)
five
times
higher
than
those
without
it.
Due
to
both
heterogeneity
and
syntropy
etiopathogenetic
mechanisms
occurrence,
prevalence
DM
increasing
world
population,
delayed
treatment
potentiates
a
poor
prognosis.
main
task
medical
community
undoubtedly
early
diagnosis
preserved
ejection
fraction
(HFpEF)
prescription
justified
pathogenetic
treatment,
especially
for
prediabetes/type
2
(T2DM).
Therefore,
strategy
pathology
use
patient-oriented
approaches
taking
into
account
gender
characteristics
search
alternative
ways
achieve
glycemic
goals
safely
HFpEF
disorders.
purpose
study
was
examine
results
12-week
course
metformin
alone
or
combination
dapagliflozin
an
emphasis
on
correction
functional
iron
deficiency
prediabetes/T2DM.
Materials
methods.
Sixty
female
who
met
criteria
were
examined
divided
two
groups:
group
I
(n
=
30)
—
prediabetes;
II
T2DM.
Depending
therapy,
patients
groups
randomized
subgroup
A
(IA:
n
15;
IIA:
15),
received
(at
daily
dose
500–2000
mg)
B
(IB:
IIB:
15)
(500–2000
mg/day)
(10
mg/day).
According
design
scientific
study,
all
at
beginning
after
12
weeks
therapy
underwent
assessment
basic
anthropometric
data,
set
laboratory
examinations,
clinical
instrumental
diagnosis.
Results.
In
IB
group,
high
effectiveness
confirmed
according
indicators
(glycated
hemoglobin
(HbA1C):
∆–10.67
%,
p
<
0.001)
significant
increase
left
ventricular
(∆+7.73
compared
receiving
(∆–1.53
>
0.5).
When
using
studied
treatments
prediabetes,
it
reliable
normalization
control
chance
(odds
ratio
0.12,
95%
confidence
interval
0.011–1.339)
preventing
additional
together
confirms
safe
transferrin
saturation
(IB/IIB
∆+38.51
0.001/∆+
29.59
0.001);
content
serum
∆+14.93
10.07
0.5)
tendency
towards
compensatory
hypoferritinemia.
On
background
(daily
2000
mg,
10
mg),
there
comparable
decrease
IIB
(IIA/IIB
HbA1C
treatment:
∆–1.75
%/∆–10.67
0.001,
respectively)
improvement
parameters
NT-pro-BNP
content:
∆–5.96
0.05/∆–13.65
0.001;
fraction:
∆+1.38
%/∆+9.00
respectively).
Conclusions.
proposed
personalized
approaches
prediabetes
have
prognosis-modifying
effect
manifestations
effective
control.
Timely
contributes
deficiency.
As
result
combined
compensation
signs
These
conclusions
contribute
better
understanding
therapeutic
potential
prevention
polypharmacy
comorbidity.
Language: Английский
The relationship between dietary inflammatory index in adults and coronary heart disease: from NHANES 1999–2018
Xu Hong,
No information about this author
Pengxin Xie,
No information about this author
Hui Liu
No information about this author
et al.
Frontiers in Nutrition,
Journal Year:
2025,
Volume and Issue:
12
Published: March 21, 2025
Background
Previous
studies
have
shown
that
pro-inflammatory
diets
increase
the
risk
of
coronary
heart
disease
(CHD)
and
all-cause
mortality.
The
dietary
inflammatory
index
(DII)
is
a
quantitative
measure
inflammation,
its
accuracy
has
been
validated
by
several
studies.
Methods
This
study
included
43,842
participants
aged
≥18
years
from
National
Health
Nutrition
Examination
Survey
(NHANES)
1999–2018.
data
CHD
was
obtained
through
questionnaire
survey,
DII
calculated
using
24-h
recall
data.
Generalized
linear
models
logistic
regression
were
used
to
determine
mediation
factors,
subgroup
analyses
conducted
evaluate
interaction
between
CHD.
Mean
decrease
in
Gini
(MDG)
importance
individual
components.
Results
age
49.81
±
18.10
years,
with
20,793
(47.4%)
being
male.
A
total
1,892
(4.3%)
diagnosed
CHD,
median
score
1.33
(0.11,
2.40).
After
adjusting
for
potential
confounders,
analysis
revealed
independently
associated
[OR:
1.049
(1.012–1.087),
p
=
0.008].
Triglyceride-glucose
index,
visceral
adiposity
body
mass
waist-to-height
ratio,
high-density
lipoprotein,
glomerular
filtration
rate
(all
<
0.05)
may
mediate
relationship
Subgroup
showed
more
sensitive
<75
(
0.001),
females
0.028),
those
low
cholesterol
levels
0.004),
individuals
Framingham
scores
0.005).
MDG
indicated
carbohydrate,
vitamin
C
iron
intake
greatest
impact
on
Conclusion
suggests
various
metabolic
lipid
indicators
play
mediating
role
greater
adverse
traditional
low-risk
populations.
Language: Английский
Visceral Adiposity Index, Premature Mortality, and Life Expectancy in US Adults
Mei Xue,
No information about this author
Xiaoqian Zhang,
No information about this author
Kening Chen
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 27, 2025
Abstract
Importance
Visceral
adiposity
index
(VAI)
vividly
reflects
body
fat
distribution
through
comprehensively
integrating
mass
index,
sex,
waist
circumference,
triglycerides,
and
high-density
lipoprotein
cholesterol.
While
VAI
is
an
established
predictor
of
various
clinical
outcomes,
its
relationship
with
premature
mortality
life
expectancy
remains
unclear.
Objective
To
explore
the
association
between
or
in
a
nationally
representative
cohort
US
adults.
Methods
This
study
included
adults
who
participated
National
Health
Nutrition
Examination
Survey
(NHANES)
from
1999
to
2018,
linked
Death
Index
December
31,
2019.
Data
were
analyzed
August
October,
2024.
was
categorized
into
quartiles
lowest
Q1
highest
Q4.
Primary
endpoints
(death
before
80
years
age)
expectancy.
Results
A
total
43,672
participants
(women:
22,164;
men:
21,508)
aged
>
20
included.
Over
median
follow-up
9.2
(IQR:
4.9–13.8),
3,187
deaths
documented.
Higher
significantly
associated
increased
multi-adjusted
risk
compared
(Q3
vs.
Q1:
hazard
ratio
[HR],
95%
confidence
interval
[CI]:
1.30,
1.05
1.61;
Q4
1.68,
1.34
2.11).
particularly
pronounced
women
1.53,
1.01
2.30;
2.36,
1.52
3.68),
significant
linear
trends
(
P
<
0.001).
Estimated
at
age
40
41.45
(95%
CI:
41.24
41.66),
41.32
(41.11
41.53),
40.55
(40.35
40.75),
39.26
(39.08
39.45)
Q1,
Q2,
Q3,
VAI,
respectively.
By
estimated
reduced
by
3.33
1.24
men,
Q1.
race
ethnicity,
it
shortened
3.90
Black
1.68
White
group,
Conclusions
In
this
nationwide
study,
higher
among
These
associations
we
heterogeneous
more
participants.
Language: Английский
ЕФЕКТИВНІСТЬ ІНГІБІТОРІВ НАТРІЙЗАЛЕЖНОГО КОТРАНСПОРТЕРУ ГЛЮКОЗИ 2 ТИПУ В КОРЕКЦІЇ ІНСУЛІНОРЕЗИСТЕНТНОСТІ У ЖІНОК РЕПРОДУКТИВНОГО ВІКУ ІЗ ЦУКРОВИМ ДІАБЕТОМ 2 ТИПУ
Art of Medicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 46 - 52
Published: April 2, 2025
As
a
result
of
insulin
resistance
(IR),
women
reproductive
age
have
higher
risk
the
development
and
progressing
type
2
diabetes
(T2DM),
which
contributes
to
decrease
in
fertility
potential.
Despite
ongoing
scientific
discoveries
fields
endocrinology
patient-centered
treatment
goals,
significant
part
global
population
lacks
compensation
for
T2DM.
Therefore,
one
alternative
approaches
treating
with
T2DM
should
be
considered
achieving
glycemic
targets
while
simultaneously
correcting
IR.
The
aim
is
evaluate
efficacy
sodium-glucose
cotransporter
inhibitors
(SGLT2i)
correction
carbohydrate
lipid
metabolism
A
12-week
study
involved
30
who
met
criteria.
Based
on
their
hypoglycemic
therapy,
participants
were
divided
into
two
groups:
group
(n=15),
received
standard
medication
therapy
(SMT)
combined
SGLT2i
(dapagliflozin
10
mg/daily
doses
or
empagliflozin
10-25
doses),
control
SMT
consisting
metformin
2000
doses,
alpha-lipoic
acid
600
inositol
doses.
groups
comparable
regarding
primary
disease
its
duration,
age,
body
composition,
anthropometric
parameters,
laboratory-instrumental
characteristics
IR,
characteristics.
Analysis
after
12
weeks
revealed
differences
outcomes
between
groups.
Women
group,
іSGLT2
as
regimen,
experienced
statistically
reduction
IR
markers.
Specifically,
HOMA-IR
index
decreased
2.3-fold
compared
baseline
values
(study
vs.
group:
∆+127.77%;
p<0.001).
Improvements
also
observed
composition:
1.4-fold
visceral
fat
content
(VFC)
1.3-fold
total
percentage
∆+38.25%;
p=0.002
∆+33.23%;
p=0.003,
respectively).
Patients
achieved
better
average
level
glycated
hemoglobin
(HbA1C)
7.26±0.86%
(p<0.001)
8.48±0.80%
representing
an
improvement
∆+16.80%
(p=0.003).
Additionally,
metabolic
age—a
crucial
indicator
overall
health—improved
significantly
group.
It
by
4.25%,
resulting
mean
48.20±4.33
years
(p<0.001),
55.07±4.59
findings
this
highlight
potential
combining
This
therapeutic
approach
not
only
achieves
but
facilitates
comprehensive
symptoms,
normalizes
metabolism,
improves
parameters.
With
favorable
safety
profile
demonstrated
efficacy,
integration
management
protocols
offers
promising
optimizing
specific
patient
population.
These
results
underscore
importance
personalized
strategies
aimed
at
addressing
both
health
Language: Английский
Visceral adiposity index, premature mortality, and life expectancy in US adults
Mei Xue,
No information about this author
Xiaoqian Zhang,
No information about this author
Kening Chen
No information about this author
et al.
Lipids in Health and Disease,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: April 15, 2025
Visceral
adiposity
index
(VAI)
vividly
reflects
body
fat
distribution
through
comprehensively
integrating
mass
index,
sex,
waist
circumference,
triglycerides,
and
high-density
lipoprotein
cholesterol.
While
VAI
is
an
established
predictor
of
various
clinical
outcomes,
its
relationship
with
premature
mortality
life
expectancy
remains
unclear.
To
explore
the
association
between
or
in
a
nationally
representative
cohort
US
adults.
This
study
included
adults
who
participated
National
Health
Nutrition
Examination
Survey
(NHANES)
from
1999
to
2018,
linked
Death
Index
December
31,
2019.
Data
were
analyzed
August
October,
2024.
was
categorized
into
quartiles
lowest
Q1
highest
Q4.
Primary
endpoints
(death
before
80
years
age)
expectancy.
A
total
43,672
participants
(women:
22,164;
men:
21,508)
aged
>
20
included.
Over
median
follow-up
9.2
(IQR:
4.9-13.8),
3,187
deaths
documented.
Higher
significantly
associated
increased
multi-adjusted
risk
compared
(Q3
vs.
Q1:
hazard
ratio
[HR],
95%
confidence
interval
[CI]:
1.30,
1.05
1.61;
Q4
1.68,
1.34
2.11).
particularly
pronounced
women
1.53,
1.01
2.30;
2.36,
1.52
3.68),
significant
linear
trends
(P
<
0.001).
Estimated
at
age
40
41.45
(95%
CI:
41.24
41.66),
41.32
(41.11
41.53),
40.55
(40.35
40.75),
39.26
(39.08
39.45)
Q1,
Q2,
Q3,
VAI,
respectively.
By
estimated
reduced
by
3.33
1.24
men,
Q1.
race
ethnicity,
it
shortened
3.90
Black
1.68
White
group,
In
this
nationwide
study,
higher
among
These
associations
we
heterogeneous
more
participants.
Language: Английский
Exploring the Relationship Between Visceral Fat and Coronary Artery Calcification Risk Using Metabolic Score for Visceral Fat (METS-VF)
Jiun‐Chi Huang,
No information about this author
Ya‐Chin Huang,
No information about this author
Chia-Hsin Lu
No information about this author
et al.
Life,
Journal Year:
2024,
Volume and Issue:
14(11), P. 1399 - 1399
Published: Oct. 31, 2024
Metabolic
Score
for
Visceral
Fat
(METS-VF)
is
a
novel
indicator
estimating
intra-abdominal
fat,
yet
its
connection
with
coronary
artery
calcification
(CAC)
remains
uncharted.
Our
research
aims
to
explore
the
METS-VF
indicator's
link
CAC
while
comparing
performance
against
relevant
anthropometric
indices.
Language: Английский